Virus Mutation Becomes an Obstacle for COVID-19 Vaccinations
The emergence of new SARS-CoV-2 virus variants will challenge COVID-19 vaccination programs being run across many countries.
/https%3A%2F%2Fkompas.id%2Fwp-content%2Fuploads%2F2021%2F03%2F9c57ef5d-a1b4-410d-80a6-036ec9900548_jpg.jpg){kind=logo}
A health worker gives a first COVID-19 vaccine dose to a vendor at Blok A Tanah Abang Market in Central Jakarta on Monday (1/3/2021). Many vendors welcomed the vaccination, and there was a long line to register. More than 23,000 vendors and management staff registered for the vaccination drive, which ran until March 2.
JAKARTA, KOMPAS — The emergence of new SARS-CoV-2 virus variants will challenge COVID-19 vaccination programs being run across many countries. Apart from being more contagious and having the potential to increase mortality, the new mutations can also reduce the effectiveness of vaccines.
“This mutation is the biggest challenge yet, we must be careful,” said Eijkman Institute molecular biology deputy head David Handojo Muljono in an online discussion in Jakarta, Friday (5/3/2021).